92 related articles for article (PubMed ID: 8380213)
1. The combined immunological and antinociceptive defects of beige-J mice: the possible existence of a 'mu-repressin'.
Raffa RB; Mathiasen JR; Kimball ES; Vaught JL
Life Sci; 1993; 52(1):1-8. PubMed ID: 8380213
[TBL] [Abstract][Full Text] [Related]
2. C57BL/6J-bgJ (beige) mice: differential sensitivity in the tail flick test to centrally administered mu- and delta-opioid receptor agonists.
Mathiasen JR; Raffa RB; Vaught JL
Life Sci; 1987 May; 40(20):1989-94. PubMed ID: 3033418
[TBL] [Abstract][Full Text] [Related]
3. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
4. The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J: Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermates.
Raffa RB; Kimball ES; Mathiasen JR
Life Sci; 1988; 42(12):1231-6. PubMed ID: 3347148
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
6. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
Kamei J; Saitoh A; Kasuya Y
Neurosci Lett; 1995 Aug; 196(3):169-72. PubMed ID: 7501275
[TBL] [Abstract][Full Text] [Related]
7. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive defect of beige-J mice reversed by i.c.v. IP3 or myo-inositol.
Raffa RB; Martinez RP
Neuroreport; 1995 Jul; 6(10):1434-6. PubMed ID: 7488742
[TBL] [Abstract][Full Text] [Related]
9. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
10. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice.
Kest B; Beczkowska I; Franklin SO; Lee CE; Mogil JS; Inturrisi CE
Brain Res; 1998 Sep; 805(1-2):131-7. PubMed ID: 9733948
[TBL] [Abstract][Full Text] [Related]
11. Effects of naltrindole and nor-binaltorphimine treatment on antinociception induced by sub-acute selective mu opioid receptor blockade.
Walker MJ; Le AD; Poulos CX
Brain Res; 1992 Dec; 599(2):204-8. PubMed ID: 1337857
[TBL] [Abstract][Full Text] [Related]
12. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
Kamei J; Zushida K; Ohsawa M; Nagase H
Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
[TBL] [Abstract][Full Text] [Related]
13. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
14. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
Chen X; Geller EB; Adler MW
Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
[TBL] [Abstract][Full Text] [Related]
15. Effect of diabetes on pinacidil-induced antinociception in mice.
Zushida K; Onodera K; Kamei J
Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
[TBL] [Abstract][Full Text] [Related]
16. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of μ-opioid and δ-opioid receptors in the antinociceptive effect caused by oral administration of m-trifluoromethyl-diphenyl diselenide in mice.
Brüning CA; Prigol M; Roehrs JA; Zeni G; Nogueira CW
Behav Pharmacol; 2010 Oct; 21(7):621-6. PubMed ID: 20729717
[TBL] [Abstract][Full Text] [Related]
18. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
19. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
20. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]